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ABSTRACT
Background: The objective was to screen and evaluate the prevalence of respiratory diseases and obs-
tructive ventilatory defects among fishermen in Morocco. 
Materials and methods: This observational and cross-sectional epidemiological study involved 924 men 
over 20 years old and with at least two years of seniority. It included a questionnaire and a spirometry. 
The questionnaire is composed of four sections: sociodemographic and occupational characteristics, toxic 
habits, medical history and respiratory clinical symptoms. 
Results: The prevalence of symptoms of tracheobronchial irritation was 9.2% for cough, 8.2% for sputum 
7.8% for dyspnoea and chest wheezing 8.1%. The frequency of rhinitis was 17.1%, asthma 6.8%, chronic 
bronchitis 5.6% and chronic obstructive pulmonary disease (COPD) 4.1% (5.4% for current and former 
smokers versus 1.1% for non-smokers). The prevalence was reaching 6.8% among those who smoked 
more than 10 pack-years and 17.9% among those who smoked more than 20 pack-years. Among subjects 
over 40 years old who had smoked more than 10 pack-years, the prevalence of COPD was 8.1%. The 
comorbidities were frequent. 
Conclusions: Smoking was very common among fishermen. Symptoms and respiratory diseases remain 
underdiagnosed and undertreated. Prevention and early detection must be a priority in this sector.
(Int Marit Health 2018; 69, 1: 13–21)
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INTRODUCTION 
In industrialised countries, obstructive pulmonary dis-
eases (bronchial asthma and chronic obstructive pulmo-
nary disease [COPD]) are a serious public health problem 
because of their frequency, severity and socio-economic 
impacts. Their actual prevalence is often underestimated, 
because unfortunately the first symptoms of the disease 
are regularly unidentified [1, 2]. In France, among adults, 
the prevalence of asthma is estimated between 6% and 
7% [3] and that of COPD between 7.5% and 10% [4]. In 
developing countries, there are few studies assessing the 
burden of COPD [5–7]. 
The increase in the prevalence of these diseases 
around the world is largely related to the increase in pol-
lution and tobacco consumption which are the main risk 
factors and which are constantly increasing in low-income 
countries [8–10]. Although the main cause is active smok-
ing, several studies have focused on the close relationship 
between these diseases and other risk factors that act from 
childhood to adulthood, such as genetic factors, passive 
smoking, childhood pulmonary infections, professional and 
household exposure [11, 12]. In Morocco, according to 
the 2014 report of the National Observatory on Drugs and 
Addictions, the number of smokers was around 34.5% of 
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the male population aged 20 and over [13]. According to 
the World Health Organisation (WHO), in 2020, if no pre-
ventive action is taken, the number of victims of tobacco in 
developing countries could reach 70% of the total number 
of victims around the world and COPD will be the third 
cause of deaths [14]. Given the frequency and severity 
of these conditions in the general population, we found 
it useful to screen fishermen particularly exposed to the 
severe weather and the danger of the Strait of Gibraltar 
and known for their heavy consumption of tobacco, can-
nabis and alcohol [15–17]. The objective of this study was 
to estimate the prevalence of respiratory symptoms and 
diseases and obstructive ventilatory defects (OVD) among 
seafarers in Morocco.
MATERIALS AND METHODS
SUBJECTS 
This observational and cross-sectional epidemiological 
study took place in two ports of northern Morocco (Tangier 
and Larache) in 2017 and concerned a representative sam-
ple of 924 males, traditional fishermen above 20 years old 
with 2 years of length of employment. They were randomly 
selected from exhaustive administrative list of 3052 fish-
ermen. The participation rate was 30.2%. 
QUESTIONNAIRE
We used an individual questionnaire [18–22], inspired 
by those of the European Coal and Steel Community (ECSC), 
British Medical Research Council (BMRC) and the American 
Thoracic Society (ATS) and WHO. It included four sections: 
 — socio-demographic and professional characteristics: 
age, body mass index (BMI), occupational history (so-
cio-professional category, length of employment);
 — toxic habits: tobacco, cannabis, alcohol;
 — medical history (concomitant chronic diseases, comor-
bidities);
 — clinical respiratory symptoms: chronic cough, breath-
ing difficulty (dyspnoea) defined according to Sadoul’s 
classification [23], chronic sputum production, chest 
wheezing, asthma, rhinitis, chronic bronchitis and COPD. 
Asthma is defined as a chronic inflammatory disease of 
the bronchi characterised by recurrent episodes of cough-
ing, wheezing, chest building and/or dyspnoea usually 
reversible spontaneously or after treatment. Suggestive 
symptoms of asthma included chest wheezing, shortness 
of breath, chest tightness or spasmodic cough caused by 
stimuli such as cold air, exercise, strong odours, smoke 
and dust. These symptoms may be associated or isolated. 
The diagnosis of asthma was confirmed by the question-
naire, the clinical examination and the reversibility of an 
eventual OVD.
Chronic obstructive pulmonary disease is a common, 
preventable and treatable disease that is characterised 
by persistent respiratory symptoms and airflow limitation 
that is due to airway and/or alveolar abnormalities usu-
ally caused by significant exposure to noxious particles or 
gases. The chronic airflow limitation that is characteristic 
of COPD is caused by a mixture of small airways disease 
(e.g. obstructive bronchiolitis) and parenchymal destruction 
(emphysema); the relative contributions of which vary from 
person to person. The criteria for its diagnosis and severity 
are those developed by the GOLD initiative [23]. The diag-
nosis is made in the presence of an OVD based on a ratio 
FEV1/FVC < 70% after administration of a bronchodilator. 
FEV1 is the forced expiratory volume at the first second and 
the FVC is the forced vital capacity.
Chronic bronchitis is defined as chronic cough and 
chronic sputum production occurring for at least 3 months 
(consecutive or not) per year and for at least 2 consecutive 
years without any other identified cause.
For smoking intoxication, we have individualised current 
smokers (CS), former smokers (FS) and non-smokers (NS). 
Subjects were classified as CS if they smoked at the time 
of the survey or if they stopped less than three months be-
fore the study and had smoked more than 100 cigarettes 
throughout their lives. FS are those who stopped more than 
3 months before the study and have smoked more than 
100 cigarettes throughout their lives. NS are those who have 
never smoked or smoked less than 100 cigarettes throughout 
their lives [24]. Tobacco consumption is quantified in pack-
years (number of packets smoked per day × number of years). 
The body mass index (BMI) is calculated by dividing the 
weight in kilograms by the square of the height in meters 
(kg/m2). The WHO has proposed the following classification: 
underweight (BMI < 18.5), normal weight (BMI 18.5–24.9), 
overweight (BMI 25–29.9), obesity (BMI ≥ 30).
SPIROMETRy
It was carried out using a  spirometer (type Winspiro) 
with disposable turbine provided already calibrated, usable 
at the output of its Pro packaging. For each person, a spi-
rometry test with three successive trials was conducted. 
The best of the three was selected considering the degree 
of cooperation of the subject and the aspect of the flow/ 
/volume curve. Parameters measured were FVC, FEV1, ratio 
(FEV1/FVC), forced expiratory flow (FEF) from 25% to 75% 
of vital capacity (FEF25–75).
Small airways defect is defined by a  FEV1/FVC ratio 
> 70% and FEF 25–75 < 80% of the predicted value.
FEV1/FVC ratio less than 70% define OVD. In this case, 
a  reversibility test was performed 15 min after inhala-
tion (via an inhalation chamber) of 400 µg of salbutamol. 
The test was considered positive at two conditions: FEV1 
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> 200 mL compared to the pretest value and ratio 
(FEV1 posttest — FEV1 pretest)/FEV1 predicted ≥ 12%. 
Classification of airflow limitation severity is based on 
post bronchodilator FEV1 value and includes four stag-
es: mild OVD (FEV1 ≥ 80% predicted value), moderate 
OVD (50% ≤ FEV1 < 80% predicted value), severe OVD 
(30% ≤ FEV1 < 50% predicted value) and very severe OVD 
(FEV1 < 30% predicted value).
PROCEDURE OF THE STUDy
We previously contacted the delegate of the Ministry 
of Marine Fisheries, the presidents of the associations of 
fishermen and the occupational physicians to explain the 
purpose of the study and obtain their support. The inter-
views, clinical examinations and spirometries took place 
at seafarers’ health antennas. The singular discussion with 
each fisherman was carried out in the respect of the confi-
dentiality after his information on the interest of our study. 
The interview lasted about 30 min for each person. The 
questions were formulated orally, if necessary translated 
into dialectal Arabic, and explained in simple terms and 
accessible to all. The fishermen answered the questionnaire 
without difficulty and with enthusiasm. 
STATISTICAL ANALySIS
The statistical analysis was performed using the SPSS 
version 11.5 software package. The differences between 
groups were compared using t tests for continuous variables 
and c2 tests for categorical ones. The statistical level of signif-
icance was established at 5%. For a proportion, we calculate 
the lower and upper limits of the 95% confidence intervals.
RESULTS
SOCIODEMOGRAPHIC AND PROFESSIONAL 
CHARACTERISTICS ACCORDING TO SMOkING 
STATUS 
The average age of our sample was 40.8 ± 10.9 years 
(range 20–71 years), of whom 43.2% were over 40 years 
old. The average BMI was 25.1 ± 3.7 kg/m2. The prevalence 
of tobacco smoking (CS+FS) was 69.9%, cannabis smoking 
was 29.9% and alcohol consumption was 38.3%. The av-
erage of length of employment was 16 ± 6.7 years. Almost 
three quarters (74.7%) of CS+FS had consumed more than 
10 pack-years. The average consumption of tobacco for 
CS+FS was 16.8 ± 5.9 pack-years. The average age of onset 
of smoking tobacco was 14.5 ± 2.1 years. The averages 
of age of CS+FS versus NS were 41.1 ± 11.1 years old 
versus 38.5 ± 10.8 years old (p < 0.7898). The averages 
of BMI were 25.1 ± 3.4 kg/m2 versus 25.6 ± 3.9 kg/m2 
(p < 0.2552). 
Average of length of employment was 16.7 ± 6.9 years 
versus 14.1 ± 7.2 years (p < 0.5015). The prevalence of 
cannabis smoking and alcohol consumption were respec-
tively 40.1% versus 6.1% (p < 0.001) and 46.1% versus 
19.1% (p < 0.001) (Table 1).
Table 1. Sociodemographic and professional characteristics according to smoking status 
Characteristics Total population 
(n = 924)
CS
431 (46.6%)
FS
215 (23.3%)
CS+FS
646 (69.9%)
NS
278 (30.1%)
Age [years]:
    20–30
    31–40 
    41–50 
    > 50 
149 (16.1%)
367 (39.7%)
201 (21.8%)
207 (22.4%)
65 (43.6%)
205 (55.9%)
79 (39.3%)
83 (40.1%)
 15 (10.1%)
71 (19.3%)
53 (26.4%)
75 (36.2%)
80 (53.7%)
276 (75.2%)
132 (65.7%)
158 (76.3%)
69 (46.3%)
91 (24.8%)
69 (34.3%)
49 (23.7%)
Quantification of cigarette  
smoking [pack–years]:
    ≤ 10
    11–20
    21–30 
    31–40
    > 40
–
–
–
–
–
109 (25.3%)
223 (51.7%)
61 (14.2%)
21 (4.9%)
17 (3.9%)
48 (22.3%)
110 (51.2%)
37 (17.2%)
8 (3.7%)
12 (5.6%)
157(24.3%)
333 (51.5%)
98 (15.2%)
29 (4.5%)
29 (4.5%)
–
–
–
–
–
BMI [kg/m2]:
    Underweight 
    Normal 
    Overweight 
    Obesity
58 (6.3%)
471 (51%)
279 (30.2%)
116 (12.6%)
37 (8.6%)
220 (51%)
139 (32.3%)
35 (8.1%)
6 (2.8%)
77 (35.8%)
84 (39.1%)
48 (22.3%)
43 (6.7%)
297 (46%)
223 (34.5%)
83 (12.8%)
15 (5.4%)
174 (62.6%)
56 (20.1%)
33 (11.9%)
Length of employment [years]:
    < 10 
    11–20 
    > 20 
195 (21.1%)
372 (40.3%)
357 (38.6%)
78 (40%)
199 (53.5%)
154 (43.1%)
18 (9.2%)
68 (18.3%)
129 (36.1%)
96 (14.9%)
267 (41.3%)
283 (43.8%)
99 (50.8%)
105 (28.2%)
74 (20.7%)
Other toxic habits:
    Cannabis
    Alcohol
276 (29.9%)
354 (38.3%)
161 (37.4%)
183 (42.5%)
98 (45.6%)
116 (54%)
259 (40.1%)
299 (46.3%)
17 (6.1%)
55 (19.8%)
BMI — body mass index; CS — current smoker; FS — former smoker; NS — no smoker
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Table 2. Prevalence of respiratory symptoms and pathologies according to smoking status 
Total population
N = 924
CS
431 (46.6%)
FS
215 (23.3%)
CS+FS
646 (69.9%)
NS
278 (30.1%)
P
Symptoms of trache-
obronchial irritation:
    Chronic cough
    Chronic sputum
    Dyspnoea
    Chest wheezing
85 (9.2%)
76 (8.2%)
72 (7.8%)
81 (8.1%)
51 (11.8%)
44 (10.2%)  
38 (8.8%)
43 (10%)
18 (8.4%)
15 (7%)
19 (8.8%)
19 (8.8%)
69 (10.7%)
59 (9.1%)
57 (8.8%)
62 (9.6%)
16 (5.9%)
17 (6.1%)
15 (5.4%)
19 (6.8%)
0.024
0.161
0.099
0.217
Rhinitis 158 (17.1%) 83 (19.3%) 41 (19.1%) 124 (19.2%) 34 (12.2%) 0.013
Asthma 62 (6.8%) 29 (6.7%) 16 (7.4%) 45 (7%) 17 (6.1%) 0.741
Chronic bronchitis 52 (5.6%) 31 (7.2%) 17 (7.9%) 48 (7.4%) 4 (1.4%) 0.0001
COPD 38 (4.1%) 24 (5.6%) 11 (5.1%) 35 (5.4%) 3 (1.1%) 0.004
COPD — chronic obstructive pulmonary disease; CS — current smoker; FS — former smoker; NS — no smoker
Table 3. Prevalence of respiratory function abnormalities according to the degree of severity and smoking status
Spirometric  
abnormalities
Total
81/924 (8.8%)
CS
42/431 (9.7%)
FS
24/215 (11.2%)
CS+FS
66/646 (10.2%)
NS
15/278 (5.4%)
P
Small airways syndrome 31 (3.4%) 16 (3.7%) 9 (4.2%) 25 (3.9%) 6 (2.2%) 0.260
Mild OVD 18 (1.9%) 9 (2.1%) 4 (1.9%) 13 (2%) 5 (1.8%) 0.965
Moderate OVD 29 (3.1%) 16 (3.7%) 9 (4.2%) 25 (3.9%) 4 (1.4%) 0.082
Severe OVD 2 (0.2%) 0 (0%) 2 (0.9%) 2 (0.3%) 0 (0%) 0.875
Very severe OVD 1 (0.1%) 1 (0.2%) 0 (0%) 1 (0.2%) 0 (0%) 0.664
CS — current smoker; FS — former smoker; NS — no smoker; OVD — obstructive ventilatory defect
PREvALENCE OF RESPIRATORy SyMPTOMS AND 
PATHOLOGIES ACCORDING TO SMOkING STATUS 
The respective prevalences of chronic cough, rhinitis, 
chronic bronchitis and COPD were significantly greater 
among CS+FS than among NS (Table 2). 
PREvALENCE OF RESPIRATORy FUNCTION 
ABNORMALITIES ACCORDING TO THE DEGREE 
OF SEvERITy AND SMOkING STATUS 
Among total population, the prevalence of ventilatory 
defect was 8.8%: 3.4% for the small airway syndrome, 1.9% 
for the mild OVD, 3.1% for the moderate OVD and 0.3% for 
the severe to very severe OVD. Prevalences of spiromet-
ric abnormalities were significantly higher among CS+FS 
than among NS (10.2% vs. 5.4%, p = 0.024). All stages of 
ventilatory defect were more frequent among CS+FS than 
among NS (Table 3). 
CLINICAL CHARACTERISTICS OF SUBJECTS wITH 
COPD ACCORDING TO TOBACCO STATUS 
Among the 38 fishermen with COPD, the average age 
was 48.4 ± 7.9 years (with extremes ranging from 32 to 
71 years) and 78.9% were over 40 years old. The associat-
ed respiratory diseases were asthma in 18.4%, rhinitis in 
23.7% and chronic bronchitis in 89.5%. The most common 
comorbidities were high blood pressure (22%), diabetes and 
metabolic syndrome (16%), cardiovascular diseases such as 
heart diseases, phlebitis and arteritis (15%), psychological 
disorders such as anxiety, depression and dyssomnia (17%), 
digestive disorders (19%) and musculoskeletal dysfunctions 
(21%). Among people with COPD, 42.5% reported no respi-
ratory symptom that could suggest the diagnosis of COPD. 
Only the 3 patients with a severe and very severe stage of 
the COPD consulted a specialist and benefited of spirometry. 
That explains the high percentage (92.1%) of undiagnosed 
COPD. The prevalence of tobacco smoking (CS+FS) was 
92.1%, cannabis smoking was 71.4% and alcohol consump-
tion was 55.3%. Among CS+FS, average of quantification of 
cigarette smoking was 29.5 ± 6.9 pack-years and 94.3% 
had smoked more than 10 pack-years. The average age of 
onset of smoking cigarette was 13 ± 1.2 years (Table 4).
CLINICAL CHARACTERISTICS OF SUBJECTS 
wITH COPD ACCORDING TO TOBACCO STATUS 
REFERRED TO TOTAL POPULATION 
Among total population, the prevalence of COPD was 
4.1% and reached 5.4% among CS+FS versus 1.1% among 
NS with significate difference (p = 0.004). The frequency 
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Table 4. Clinical characteristics of subjects with chronic obstructive pulmonary disease according to tobacco status
Total
38 (100%)
FS
24 (63.2%)
CS
11 (28.9%)
FS+CS
35 (92.1%)
NS
3 (7.9%)
Age [years]:
    20–30
    31–40 
    41–50 
    > 50 
0 (0%)
8 (21%)
9 (23.7%)
21 (55.3%)
0 (0%)
7 (29.2%)
5 (20.8%)
12 (50%)
0 (0%)
1 (9.1%)
3 (27.3%)
7 (63.6%)
0 (0%)
8 (22.9%)
8 (22.9%)
19 (54.3%)
0 (0%)
0 (0%)
1 (33,3)
2 (66,7)
BMI [kg/m2]:
    Underweight
    Normal  
    Overweight
    Obesity
11 (28.9%)
16 (42.1%) 
8 (21.1%)
3 (7.9%)
9 (37.5%)
11 (45.8%)
4 (16.7%)
0 (0%)
2 (18.2%)
4 (36.4%)
3 (27.3%)
2 (18.2%)
11 (31.4%)
15 (42.9%)
7 (20%)
2 (5.7%)
0 (0%)
1 (33.3%)
1 (33.3%)
1 (33.3%)
Quantification of cigarette 
smoking (pack-years):
    ≤ 10
    11–20
    21–30 
    31–40
    > 40
–
–
–
–
–
1 (4.2%)
3 (12.5%)
6 (25%)
7 (29.2%)
7 (29.2%)
1 (9.1%)
2 (18.2%)
2 (18.2%)
2 (18.2%)
4 (36.4%)
2 (5.7%)
5 (14.3%)
8 (22.9%)
9 (25.7%)
11 (31.4%)
–
–
–
–
–
Severity of COPD:
    Mild
    Moderate
    Severe
    Very severe
11 (28.9%)
24 (63.2%)
2 (5.3%)
1 (2.6%)
7 (29.2%)
16 (66.7%)
0 (0%)
1 (4.2%)
2 (18.2%)
7 (63.6%)
2 (18.2%)
0 (0%)
7 (20%)
25 (71.4%)
2 (5.7%)
1 (2.8%)
2 (66.7%)
1 (33.3%)
0 (0%)
0 (0%)
Associated respiratory  
diseases:
    Rhinitis
    Asthma
    Chronic bronchitis
9 (23.7%)
7 (18.4%)
34 (89.5%)
3 (12.5%)
3 (12.5%)
21 (87.5%)
4 (36.4%)
2 (18.2%) 
10 (90.9%)
7 (20%)
5 (14.3%)
31 (88.6%)
2 (66.7%)
2 (66.7%)
3 (100%)
Other toxic habits:
    Cannabis
    Alcohol 
26 (68.4%)
21 (55.3%)
17 (70.8%)
11 (45.8%)
8 (72.7%)
10 (90.9%)
25 (71.4%)
21 (60%)
1 (33.3%)
0 (0%)
BMI — body mass index; COPD — chronic obstructive pulmonary disease; CS — current smoker; FS — former smoker; NS — no smoker
was 6.7% among those who smoked more than 10 pack-
years and 17.9% among those who smoked more than 
20 pack-years. This prevalence was 2.2% among CS+FS un-
der 40 years old versus 9.3% among those over 40 years old 
(p = 0.0001). In subjects over 40 years old and had smoked 
more than 10 pack-years, it was 8.1%. Among NS, it was 
equal 2.5% for those over 40 years old (Table 5). 
CLINICAL FEATURES IN SUBJECTS wITH COPD 
ACCORDING TO DEGREE OF SEvERITy 
92.1% of those with COPD are at mild and moderate 
stages and 77.1% are over 40 years old. For the severe and 
very severe stages, all people were over 40 years old and had 
a polyaddiction to tobacco, cannabis and alcohol (Table 6).
DISCUSSION 
The prevalence of toxic habits is constantly increasing in 
developing countries and all professional sectors and activ-
ities are affected [13, 25]. Seafarers are a particular target 
because of the dangerousness and complexity of their work. 
This laborious activity, with irregular and atypical work and 
numerous constraints, requires courage and commitment of 
fishermen. In these countries, risk-taking behaviour among 
artisanal fishermen is still an observational epidemiological 
reality, associated with significant morbidity and mortality. 
These dangerous behaviours are very diverse and include 
high prevalence of psychoactive substance use [15, 16]. 
Addictive behaviours (particularly smoking tobacco and 
cannabis) are very common among the fishermen who 
suffer of health problems and poor access to healthcare 
utilities. In our study, the prevalence of tobacco smoking was 
46.6%, cannabis smoking 29.9% and alcohol consumption 
38.3%. Two other surveys [15, 16], the first relating to risk 
behaviours and the second to the consumption of addictive 
substances among Moroccan fishermen, showed similarly 
high rates of tobacco smoking (58.5% and 52.3%), canna-
bis smoking (36.2% and 31.7%) and alcohol consumption 
(36.5% and 38.9%). These prevalences are significantly 
higher than the general male population over the age of 20, 
which are respectively 34.5%, 9% and 14% [13].  
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Table 5. Clinical characteristics of subjects with chronic obstructive pulmonary disease according to tobacco status referred to total 
population 
Total
38/924 (4.1%)
CS
24/431 (5.6%)
FS
11/215 (5.1%)
CS+FS
35/646 (5.4%)
NS
3/278 (1.1%)
Age [years]:
    20–30
    31–40
    41–50
    > 50 
0
8/367 (2.2%)
9/201 (4.5%)
21/207 (10.1%)
0
7/205 (3.4%)
5/79 (6.3%)
12/83 (14.5%)
0
1/71 (1.4%)
3/53 (5.7%)
7/75 (9.3%)
0
8/276 (2.9%)
8/132 (6.1%)
19/158 (12%)
0
0 
1/69 (1.4%)
 2/49 (4.1%)
BMI [kg/m2]:
    Underweight 
    Normal
    Overweight
    Obesity
11/58 (19%)
16/471 (3.4%) 
8/279 (2.9%)
3/116 (2.6%)
9/37 (24.3%)
11/220 (5%)
4/139 (2.9%)
0/35
2/6 (33.3%)
6/77 (7.8%)
3/84 (3.6%)
2/48 (4.2%)
11/43 (25.6%)
15/297 (5.1%)
7/223 (3.1%)
2/83 (2.4%)
0
1/174 (0.6%)
1/56 (1.8%)
1/33 (3%)
Importance du smoking  
(pack-years):
    ≤ 10
    11–20
    21–30
    31–40
    > 40
–
–
–
–
–
1/109 (0.9%)
3/223 (1.3%)
6/61 (9.8%)
7/21 (33.3%)
7/17 (41.1%)
1/48 (2.1%)
2/110 (1.8%)
2/37 (5.5%)
2/8 (25%)
4/12 (33.3%)
2/157 (1.3%)
5/333 (1.5%)
8/98 (8.2%)
9/29 (31%)
11/29 (37.9%)
–
–
–
–
–
Other toxic habits:
    Cannabis
    Alcohol
26/276 (9.4%)
21/354 (5.9%)
17/161 (10.6%)
11/183 (6%)
8/98 (8.2%)
10/116 (8.6%)
25/259 (9.7%)
21/299 (7%)
1/17 (5.9%)
0
Severity of COPD:
    Light
    Moderate
    Severe
    Very severe
11/18 (61.1%)
24/29 (82.8%)
2/2 (100%)
1/1 (100%)
7/9 (77.8%)
16/16 (100%)
0
1/1 (100%)
2/4 (50%)
7/9 (77.8%)
2/2 (100%)
0
7/13 (53.8%)
25/25 (100%)
2/2 (100%)
1/1 (100%)
2/5 (40%)
1/4 (25%)
0
0
Respiratory associated  
diseases:
    Rhinitis
    Asthma
    Chronic bronchitis
9/158 (5.7%)
7/62 (11.3%)
34/52 (65.4%)
3/83 (3.6%)
3/29 (10.3%)
21/31 (67.7%)
4/41 (9.8%)
2/16 (12.5%) 
10/17 (58.8%)
7/124 (5.6%)
5/45 (11.1%)
31/48 (64.6%)
2/34 (5.9%)
2/17 (11.8%)
3/4 (75%)
COPD — chronic obstructive pulmonary disease; CS — current smoker; FS — former smoker; BMI — body mass index; NS — no smoker
Table 6. Clinical features in subjects with chronic obstructive pulmonary disease according to degree of severity
Obstructive ventilatory 
defects
Total
38 (100%)
Light
11 (28.9%)
Moderate
24 (63.2%)
Severe
2 (5.3%)
very severe
1 (2.6%)
Age [years]:
    31–40 
    41–50 
    > 50 
8 (21.1%)
9 (23.7%)
21 (55.3%)
2 (18.2%)
3 (27.3%)
6 (54.5%)
6 (25%)
5 (20.8%)
13 (54.2%)
0 (0%)
1 (50%)
1 (50%)
0 (0%)
0 (0%)
1 (100%)
Body mass index [kg/m2]:
    Underweight 
    Normal 
    Overweight
    Obesity
11 (28.9%)
18 (47.4%)
6 (15.8%)
3 (7.9%)
0 (0%)
6 (54.5%)
4 (36.4%)
1 (9.1%)
2 (8.3%)
19 (79.2%)
1 (4.2%)
2 (8.3%)
1 (50%)
1 (50%)
0 (0%)
0 (0%)
0 (0%)
1 (100%)
0 (0%)
0 (0%)
Smoking tobacco 35 (92.1%) 8 (72.7%) 24 (100%) 2 (100%) 1 (100%)
Smoking cannabis 26 (68.4%) 6 (54.5%) 17 (70.8%) 2 (100%) 1 (100%)
Consuming alcohol 21 (55.3%) 5 (45.5%) 13 (54.2%) 2 (100%) 1 (100%)
In our study, the prevalence of asthma in the total 
population was 6.8% (7% among CS+FS vs. 6.1% among 
NS, p = 0.741) and 7.3% for chronic bronchitis (9.1% 
among CS+FS vs. 2.9% among NS, p = 0.0001). In a me-
ta-analysis [26] of 38 studies, the combined prevalence 
of chronic bronchitis was 6.4%. Among adults in France, 
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the prevalence of asthma was estimated between 6% 
and 7% [3]. 
The prevalence of COPD in our total population was 
4.1% (5.4% among CS+FS vs. 1.1% among NS, p = 0.004). 
It reached 6.7% among those who smoked more than 
10 pack-years and 17.9% among those who smoked more 
than 20 pack-years. In a multicentric study of 62,086 sub-
jects in eleven countries, including Morocco, 3.5% fulfilled 
the “epidemiological” definition of COPD of whom 47.5% 
reported experiencing an exacerbation of their respiratory 
condition [6, 7]. In France the prevalence of COPD is esti-
mated between 7.5% and 10% [4]. The combined COPD 
prevalence 7.6%, found in a meta-analysis of 37 studies 
using the GOLD diagnostic criteria [26] is comparable to our 
result, which is 5.4%. The prevalence of COPD increases with 
age. In our study, among CS+FS, it is 2.2% among people 
under 40 years old against 9.3% among those over 40 years 
old. For NS, it is equal to 0% for those under 40 years old 
against 2.5% for those over 40 years old. In the literature, 
the prevalence of physiologically defined COPD in adults over 
40 years old is 9–10% [26]. In the BOLD study, the prev-
alence of COPD has doubled for every decade [27]. In our 
study, it was equal to 2.9% between 30 and 40 years, 6.1% 
between 40 and 50 years and 12% over 50 years.
In the Algerian study [5], the prevalence of COPD was 
4.9% and reached 16.1% among men over 40 years of 
age. It was 25.7% among smokers versus 2.5% among 
NS. In our study, the prevalence of COPD among subjects 
over 40 years old was 7.4% and among smokers over 
40 years old was 9.3%. These high frequencies in Algiers 
can be explained by a  higher prevalence of smokers up 
to 62% and greater quantification of cigarette smoking, 
which is 15 pack-years among 69.3% and 30 pack-years 
among 38.5%. In our study, only 24.2% smoked more than 
10 pack-years and 9% more than 30 pack-years. 
Nonsmokers may also develop COPD, which is the re-
sult of a complex interplay long-term cumulative exposure 
to noxious gases and particles combined with a variety of 
host factors including genetics, airway hyper-responsive-
ness and poor lung growth during childhood [28–30]. In 
many developing countries air pollution resulting from the 
burning of wood and other biomass fuels and occupational 
exposure including dust chemical agents and fumes are 
major COPD risk factors [31, 32]. There is strong evidence 
that the prevalence of smoking and the risk of developing 
COPD are inversely related to educational level and socio-
economic status [24, 33]. Among our fishermen with COPD, 
7.9% were NS. This prevalence resulted of occupational risk 
factors, of which the most important were severe weather, 
night work, exposure to air pollution (engine gases, passive 
smoking) and low socioeconomic status. A literature review 
conducted by the American Thoracic Society reported that 
the risk fraction attributable to occupational aetiologies was 
approximately 15% for chronic bronchitis (11% to 26%) and 
19% for obstructive airway disease [34]. In our study, 11.9% 
of chronic bronchitis and 18% of OVD were found among 
NS. Recent studies suggest an additive effect of smoking 
and occupational exposure to the risk of developing COPD 
in people exposed to gas, dust, fumes and steam [35]. 
Several nuisances or professional sectors and activities 
have been associated epidemiologically with an excess risk 
of COPD, especially mining industry, construction, public 
works, iron and steel [2], to which we could add fishermen. 
In our study, the prevalence of severity stages of COPD was 
36% mild, 58%, moderate, 4%  severe and 2% very severe. 
This distribution is comparable to that observed in the 
Algiers study: 65.5%, 29.4%, 3.3% and 2.2% [5]. COPD is 
underdiagnosed, inadequately assessed and treated while 
it is a potentially serious chronic progressive respiratory 
which is a global burden and requires long-term treatment. 
In a  multicentric study [7], only 31.8% claimed to have 
received a diagnosis of COPD from a physician and 20.6% 
had undergone spirometry in the previous year. In our study, 
42.5% of people with COPD did not report any respiratory 
symptoms that could suggest the diagnosis. This is due 
to the trivialisation of functional symptoms including dys-
pnoea when it exists especially in smokers. Only 3 patients 
with a severe and very severe stage of the disease had 
benefited from spirometry (7.9%) which explains the high 
percentage (92.1%) of underdiagnosed COPD. This high 
frequency of under-diagnosis varies according to studies 
from 45% to 97% [28]. In our study, only half (50.1%) of 
chronic bronchitis had associated COPD (52.5% for CS+FS 
and 37.5% for NS). COPD can progress from chronic bron-
chitis or appear insidiously without pre-existing chronic 
bronchitis, making diagnosis often difficult. In our country, 
the diagnosis of COPD is usually late; it occurs during an 
exacerbation with significant dyspnoea and/or an episode 
of infection in large hospitals or specialized medical office 
in large cities.
LIMITATIONS OF THE STUDy
Our study has two main limitations. It is cross-sectional; 
the healthy worker effect constitutes a bias of selection. The 
weak points of the self-declaration must be underlined espe-
cially for the consumption of the psychoactive substances 
with in the first place the alcohol. The prevalence of alcohol 
consumption is most likely underestimated because the 
Muslim confession of our target population prohibits its 
consumption and the related issues remain taboo.
CONCLUSIONS
The prevalence of chronic occupational respiratory dis-
eases is a serious public health and occupational health 
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problem. The occupational physicians should take the neces-
sary time to reduce this burden by primary prevention (fight 
against active and passive smoking and occupational pollu-
tion) and secondary prevention (early screening, monitoring, 
and following up of affected patients). The impact of these 
diseases on the daily activities of the patient is a major ele-
ment and should be systematically and rigorously evaluated. 
Several professional activities have been associated with 
an excess of risk factors of chronic respiratory diseases [2] 
to which we could add the fishery sector.
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